Be at the Core of Circular and Self-Amplifying RNA Innovation

Why Partner?

The Circular and Self-Amplifying RNA Therapeutics Summit offers solution providers a rare opportunity to engage directly with the companies defining the future of RNA medicine. As circRNA and saRNA programs progress from platform validation to IND-enabling execution, developers are actively seeking external partners to solve challenges across material quality, delivery optimization, preclinical validation, and clinical readiness.

This summit convenes senior scientists, platform leaders, and decision-makers from biotech and pharma who are responsible for selecting vendors that can support durability, redosing, manufacturability, and regulatory alignment. With a focused audience and a single-community format, conversations move beyond theory and into practical outsourcing decisions.

By partnering, your brand is positioned at the center of critical discussions around RNA synthesis, formulation development, preclinical testing, and translational strategy.

Extensive built-in networking, targeted meeting opportunities, and high visibility across the event ensure you connect with the teams actively building and scaling circular and self-amplifying RNA pipelines.

Whether you provide foundational materials, development services, or advanced delivery solutions, this is your opportunity to support programs moving toward the clinic and become a trusted partner in next-generation RNA therapeutics.

 

12 (1)

What to Expect?

Meet New Clients

Engage face-to-face with biotech founders, translational scientists, and pharma leaders who are actively sourcing reagents, CRO support, formulation expertise, and development partners.

Position Your Brand Within RNA Innovation

Increase visibility across the summit website, brochure, and onsite experience, placing your brand alongside the companies advancing circular and self-amplifying RNA into the clinic.

Demonstrate Your Expertise

Showcase your capabilities through speaking opportunities, exhibition spaces, workshops, and targeted networking aligned to the summit’s highly technical agenda.

Gain Strategic Market Insights

Hear directly from leading RNA developers such as Strand, Replicate, and Sail Biomedicines to understand evolving requirements around synthesis quality, delivery optimization, preclinical validation, and IND readiness.

Key Services & Solutions

Our attendees from next-generation RNA biopharma are looking for service and solution providers with capabilities in, but not limited to, the below areas:

  • Reagents, Enzymes, and RNA Building Blocks
    Support RNA development with high-purity modified nucleotides, IVT enzymes, capping reagents, and specialty chemistries.
  • Plasmid DNA and Template Manufacturing
    Provide GMP and research-grade plasmid DNA production to enable scalable circRNA and saRNA workflows.
  • RNA Synthesis and Process Development
    Enable robust RNA production through IVT optimization, circularization strategies, and quality analytics.
  • Delivery System Research and Optimization
    Support formulation design through lipid library screening, polymer systems, and microfluidics-based R and D platforms.
  • Preclinical CRO Services
    Deliver in vitro and in vivo studies including expression durability, biodistribution, immunogenicity, and GLP toxicology.
  • Clinical Development and Trial Execution
    Manage early-phase clinical trials, biostatistics, clinical operations, and regulatory submissions.
  • CMC and Regulatory Support Services
    Guide IND-enabling strategy with expertise in analytical development, comparability, and regulatory documentation.
  • Manufacturing Scale-Up and Tech Transfer
    Assist with transition from research to GMP production, including process scale-up and manufacturing readiness.
9

Hear What Our Past Attendees Have to Say

Keylicon bio logo (3)

It was a great meeting to network with thought leaders and learn about RNA therapeutics, their promise, and the challenges they face.

Anitaben Tailor, Global Technical Marketing Manager, Merck KGaA

Keylicon bio logo (4)

Great opportunity to connect with science and the field in general.

Nathaniel Wang, Chief Executive Officer & Co-Founder, Replicate Bioscience

Keylicon bio logo (5)

A great opportunity to learn and to network; bought together stakeholders from virtually all aspects of RNA therapeutics.

James Ferguson, Chief Medical Officer, Matinas BioPharma

Attending Companies Include

Able Sciences
Altamira Therapeutics
Chimeron Bio
Circio
Circode Logo
CSL Logo
HDT Bio
NoctuRNA Therapeutics
Replicate Bioscience
RNARevive
Rothwell Figg
Sail Biomedicine
Strand therapeutics
SunVax mRNA Therapeutics
University of British Columbia
University of Maryland

Get in Touch

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Maddie Woodside

Business Development Manager

14 (1)
Maintain Your Competitive Edge

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.

20
Network With Decision-Makers

Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.

1 (1)
Showcase Your Capabilities

Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.